Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

62 recalls, newest first

Class II · Moderate risk

Propofol Injectable Emulsion

Presence of Particulate Matter: The firm received a complaint of an embedded particulate in the neck of one vial composed primarily of iron.

Terminated Particulate / foreign matter Hospira Inc. NDC 0409-4699-30 D-0381-2015
Class I · High risk

0.9% Sodium Chloride Injection USP

Presence of Particulate Matter: Confirmed customer complaints received for the presence of blue plastic, identified as fragments of the frangible from the vial adapter.

Terminated Particulate / foreign matter Baxter Healthcare Corp NDC 0338-0553-18 D-481-2015
Class II · Moderate risk

HydrALAZINE Hydrochloride Tablets

Presence of Foreign Substance: Par Pharmaceutical, Inc. is recalling one lot of HydrALAZINE Hydrochloride tablets due to the presence of small aluminum particles.

Terminated Particulate / foreign matter Par Pharmaceutical Inc. D-0332-2015
Class I · High risk

1% LIDOCAINE HCl Injection

Presence of particulate matter: A returned customer sample was evaluated and found to have human hair attached to a pinched area of the stopper.

Terminated Particulate / foreign matter Hospira Inc. NDC 0409-4279-02 D-0391-2015
Class III · Low risk

BENZONATATE Capsules

Presence of Foreign Capsules/Tablets: Benzonatate 100 mg co-mingled with benzonatate 200 mg capsules.

Terminated Particulate / foreign matter Zydus Pharmaceuticals USA Inc D-0289-2015
Class I · High risk

Heparin Sodium

Presence of Particulate Matter: A particulate, confirmed as human hair, was found sealed between the tube and film at the round seal of the unused administrative port of the container.

Terminated Particulate / foreign matter Hospira Inc. NDC 0409-7620-03 D-0324-2015
Class II · Moderate risk

Bupivacaine HCl Inj.

Presence of Particulate Matter: A confirmed customer complaint reported the presence of a brown, rust-colored particle embedded at the bottom of the glass vial.

Terminated Particulate / foreign matter Hospira Inc. NDC 0409-1162-02 D-1588-2014
Class I · High risk

CUBICIN (daptomycin for injection)

Presence of Particulate Matter: Foreign particulate matter (tiny black specs) were observed at the bottom of the vial following reconstitution.

Terminated Particulate / foreign matter Cubist Pharmaceuticals, Inc. NDC 67919-011-01 D-0229-2015
Class I · High risk

Dianeal Low Calcium

Presence of Particulate Matter: particulate matter was found during the manufacturing process.

Terminated Particulate / foreign matter Baxter Healthcare Corp. NDC 0941-0457-05 D-1610-2014
Class II · Moderate risk

ProSol - sulfite-free

Presence of Particulate Matter: identification of particulates in a retention sample that have been identified as a mixture of the amino acid leucine and inorganic material (containing iron, silicone and chlorine).

Terminated Particulate / foreign matter Baxter Healthcare Corp NDC 0338-0499-06 D-1542-2014
Class II · Moderate risk

Alprazolam Tablets

Presence of Foreign Substance; tablets may contain stainless steel metal particulates

Terminated Particulate / foreign matter Mckesson Packaging Services NDC 63739-644-10 D-1515-2014
Class I · High risk

Lidocaine HCl Injection

Presence of Particulate Matter: The product was discolored and contained visible particulates (iron oxide) in the solution and embedded in the glass vial.

Terminated Particulate / foreign matter Hospira Inc. NDC 0409-2066-05 D-0020-2015
Class II · Moderate risk

Alprazolam Tablets

Presence of Foreign Substance; tablets may contain stainless steel metal particulates

Terminated Particulate / foreign matter Sandoz Incorporated NDC 0781-1061-10 D-1509-2014
Class I · High risk

Marcaine (bupivacaine HCl)

Presence of Particulate Matter: Confirmed customer complaint of discolored solution with visible metal particles embedded in the glass vial and visible in the solution.

Terminated Particulate / foreign matter Hospira Inc. NDC 0409-1560-29 D-0002-2015

Recalls by year